Genetic Analysis AS (GEAN)

Currency in NOK
0.65
-0.02(-2.99%)
Closed·
GEAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.650.68
52 wk Range
0.561.10
Key Statistics
Bid/Ask
0.63 / 0.68
Prev. Close
0.65
Open
0.65
Day's Range
0.65-0.68
52 wk Range
0.56-1.1
Volume
16.63K
Average Volume (3m)
30.57K
1-Year Change
-35.6436%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GEAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Jun 03, 2026
EPS / Forecast
-0.07 / --
Revenue / Forecast
4.39M / --
EPS Revisions
Last 90 days

GEAN Income Statement

Compare GEAN to Peers and Sector

Metrics to compare
GEAN
Peers
Sector
Relationship
P/E Ratio
−3.9x−3.7x−0.4x
PEG Ratio
−0.100.000.00
Price/Book
2.0x0.6x2.6x
Price / LTM Sales
2.1x4.7x3.0x
Upside (Analyst Target)
-69.9%55.7%
Fair Value Upside
Unlock14.4%8.1%Unlock

Genetic Analysis AS, a science-based diagnostic company, engages in the research, development, manufacturing, and sale of diagnostic test solutions for human microbiome in the United States, Europe, and internationally. The company offers GA-map MHI Gut Health Test, a microbiome-based diagnostic test for antibiotic-induced microbiome imbalances; GA-map Dysbiosis Test, a diagnostic microbiome test that detects and characterizes dysbiosis; GA-map Discovery, a microbiome research assay; GA-map Sample Collection Kit for the collection, transport, and storage of fecal specimens for nucleic acid analysis; GA-map IBD Precision Dx, a biomarker for inflammatory bowel disease; and GA-map COVID-19 Fecal Test, a qualitative real time standardized PCR test for the detection of the 2019 novel coronavirus RNA in stool samples. It is also involved in the operation of service laboratory where customers can send samples for microbiome profiling analysis; and provision of bioinformatic analysis and custom panel services. The company was founded in 2008 and is headquartered in Oslo, Norway.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
50.54M73.15%33.76M
Public Companies & Retail Investors
18.55M26.85%12.39M
Total
69.09M100.00%46.15M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bio-Rad Laboratories, Inc.23.97%16,562,01611,063
Avanza Fonder AB9.86%6,809,4864,549

FAQ

What Is the Genetic Analysis AS (GEAN) Stock Price Today?

The Genetic Analysis AS stock price today is 0.65 NOK.

What Stock Exchange Does Genetic Analysis AS Trade On?

Genetic Analysis AS is listed and trades on the Spotlight Stock Market.

What Is the Stock Symbol for Genetic Analysis AS?

The stock symbol for Genetic Analysis AS is "GEAN."

What Is the Genetic Analysis AS Market Cap?

As of today, Genetic Analysis AS market cap is 44.91M NOK.

What Is Genetic Analysis AS's Earnings Per Share (TTM)?

The Genetic Analysis AS EPS (TTM) is -0.17.

When Is the Next Genetic Analysis AS Earnings Date?

Genetic Analysis AS will release its next earnings report on Sep 02, 2026.

From a Technical Analysis Perspective, Is GEAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genetic Analysis AS Stock Split?

Genetic Analysis AS has split 0 times.

How Many Employees Does Genetic Analysis AS Have?

Genetic Analysis AS has 18 employees.

What is the current trading status of Genetic Analysis AS (GEAN)?

As of Jun 25, 2026, Genetic Analysis AS (GEAN) is trading at a price of 0.65 NOK, with a previous close of 0.65 NOK. The stock has fluctuated within a day range of 0.65 NOK to 0.68 NOK, while its 52-week range spans from 0.56 NOK to 1.10 NOK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.